Continuous glucose monitoring (CGM) has emerged as a valuable tool for managing type 2 diabetes mellitus, particularly in patients requiring intensive glycemic control. By providing real-time glucose data and trend insights, CGM enables physicians to make informed adjustments to therapy, improving glycemic variability and time-in-range. It is especially beneficial for patients on insulin therapy or those with frequent hypoglycemic episodes, as it helps identify unrecognized glucose fluctuations.
Incorporating CGM into patient care can enhance adherence to treatment plans through personalized feedback and actionable data. Despite its benefits, the cost and accessibility of CGM remain barriers, warranting careful patient selection and advocacy for broader access. Join us in celebrating our 11 th Anniversary with an enlightening webinar titled “CGM for Type 2 Diabetes Mellitus” by eminent…
